James Hagood
Director of the Program for Rare and Interstitial Lung Disease · University of North Carolina Hospitals
Credentials: · · · · ·
History
PresentProgram for Rare and Interstitial Lung Disease · University of North Carolina Hospitals
PresentProgram for Rare and Interstitial Lung Disease · University of California (San Diego) Medical Center
1991–1994
Research
Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis
Review · American Journal of Respiratory Cell and Molecular Biology · 2015 · 394 citations
Review · American Journal of Respiratory and Critical Care Medicine · 2013 · 353 citations
Review · The FASEB Journal · 2006 · 288 citations
13 papers
8 papers
8 papers
7 papers · 2 as a fellow
7 papers
7 papers
6 papers
6 papers
Grants
- 2024–2028
Localizing Therapeutics to Target Lung Myofibroblasts and Reverse Fibrosis
National Heart, Lung, and Blood Institute · R01
PI · $2.4M · Proteogenomics Research Instit/Sys/ Med
- 2018–2022
KULMAP: Human Kidney, Urinary Tract and Lung Mapping Center
National Heart, Lung, and Blood Institute · U54
PI · $5.5M · University of California, San Diego
- 2022
Novel Targeted Therapies for Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · P01
Project lead · $2.5M · Proteogenomics Research Instit/Sys/ Med
- 2014–2020
National Heart, Lung, and Blood Institute · U01
PI · $3.7M · University of Alabama at Birmingham